Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation

Background: The majority of mixed-fed infants with non-IgE-mediated cow's milk protein allergy (CMPA) enteropathies are managed with an extensively hydrolysed cow's milk based infant formula (eHF). Given the high variability in peptide distribution of available eHFs, it is important to und...

Full description

Bibliographic Details
Main Authors: Mikaela Sekkidou, Leilani Muhardi, Constantina Constantinou, Urszula Kudla, Yvan Vandenplas, Nicolaos Nicolaou
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Allergy
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2021.676075/full
_version_ 1818595480650645504
author Mikaela Sekkidou
Leilani Muhardi
Constantina Constantinou
Urszula Kudla
Yvan Vandenplas
Nicolaos Nicolaou
Nicolaos Nicolaou
author_facet Mikaela Sekkidou
Leilani Muhardi
Constantina Constantinou
Urszula Kudla
Yvan Vandenplas
Nicolaos Nicolaou
Nicolaos Nicolaou
author_sort Mikaela Sekkidou
collection DOAJ
description Background: The majority of mixed-fed infants with non-IgE-mediated cow's milk protein allergy (CMPA) enteropathies are managed with an extensively hydrolysed cow's milk based infant formula (eHF). Given the high variability in peptide distribution of available eHFs, it is important to understand the suitability of a specific product in the management of distinct phenotypes.Objective: To assess the symptom resolution of various phenotypes of clinical manifestations of CMPA enteropathies and constipation managed by a casein-based eHF.Methods: The data of 20 full-term infants (n = 15 with non-IgE-mediated CMPA and n = 5 with constipation) attending a paediatric allergy clinic in Cyprus and managed with a casein-based eHF were retrospectively analysed.Results: Based on the clinical symptoms and history, infants were classified into the following phenotypes: (a) 11/15 (73.3%) FPIAP, (b) 3/15 (20%) FPIES, and (c) 1/15 (6.7%) severe diarrhoea. Overall, 14 (93.3%) patients were successfully managed with the casein-based eHF and 1 (6.7%) required an AAF. This formula was effective in 91% of patients with FPIAP, in 100% with FPIES and with diarrhoea. Three (60%) patients with constipation responded to the eHF.Conclusion: This case-series report supports the efficacy of a particular casein-based eHF for the nutritional management of non-IgE mediated CMPA enteropathies.
first_indexed 2024-12-16T11:16:41Z
format Article
id doaj.art-0827a6d848664a9abf70f8301d9723e6
institution Directory Open Access Journal
issn 2673-6101
language English
last_indexed 2024-12-16T11:16:41Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Allergy
spelling doaj.art-0827a6d848664a9abf70f8301d9723e62022-12-21T22:33:34ZengFrontiers Media S.A.Frontiers in Allergy2673-61012021-06-01210.3389/falgy.2021.676075676075Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and ConstipationMikaela Sekkidou0Leilani Muhardi1Constantina Constantinou2Urszula Kudla3Yvan Vandenplas4Nicolaos Nicolaou5Nicolaos Nicolaou6N Asthma and Allergy Center, Limassol, CyprusFriesland Campina AMEA, Singapore, SingaporeUniversity of Nicosia Medical School, Nicosia, CyprusFrieslandCampina, Amersfoort, NetherlandsKidz Health Castle University Hospital Brussels, Brussels, BelgiumN Asthma and Allergy Center, Limassol, CyprusUniversity of Nicosia Medical School, Nicosia, CyprusBackground: The majority of mixed-fed infants with non-IgE-mediated cow's milk protein allergy (CMPA) enteropathies are managed with an extensively hydrolysed cow's milk based infant formula (eHF). Given the high variability in peptide distribution of available eHFs, it is important to understand the suitability of a specific product in the management of distinct phenotypes.Objective: To assess the symptom resolution of various phenotypes of clinical manifestations of CMPA enteropathies and constipation managed by a casein-based eHF.Methods: The data of 20 full-term infants (n = 15 with non-IgE-mediated CMPA and n = 5 with constipation) attending a paediatric allergy clinic in Cyprus and managed with a casein-based eHF were retrospectively analysed.Results: Based on the clinical symptoms and history, infants were classified into the following phenotypes: (a) 11/15 (73.3%) FPIAP, (b) 3/15 (20%) FPIES, and (c) 1/15 (6.7%) severe diarrhoea. Overall, 14 (93.3%) patients were successfully managed with the casein-based eHF and 1 (6.7%) required an AAF. This formula was effective in 91% of patients with FPIAP, in 100% with FPIES and with diarrhoea. Three (60%) patients with constipation responded to the eHF.Conclusion: This case-series report supports the efficacy of a particular casein-based eHF for the nutritional management of non-IgE mediated CMPA enteropathies.https://www.frontiersin.org/articles/10.3389/falgy.2021.676075/fullcasein-based extensively hydrolysed infant formulanon-IgE-mediated CMPAFPIESFPIAPFPEconstipation
spellingShingle Mikaela Sekkidou
Leilani Muhardi
Constantina Constantinou
Urszula Kudla
Yvan Vandenplas
Nicolaos Nicolaou
Nicolaos Nicolaou
Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation
Frontiers in Allergy
casein-based extensively hydrolysed infant formula
non-IgE-mediated CMPA
FPIES
FPIAP
FPE
constipation
title Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation
title_full Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation
title_fullStr Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation
title_full_unstemmed Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation
title_short Nutritional Management With a Casein-Based Extensively Hydrolysed Formula in Infants With Clinical Manifestations of Non-IgE-Mediated CMPA Enteropathies and Constipation
title_sort nutritional management with a casein based extensively hydrolysed formula in infants with clinical manifestations of non ige mediated cmpa enteropathies and constipation
topic casein-based extensively hydrolysed infant formula
non-IgE-mediated CMPA
FPIES
FPIAP
FPE
constipation
url https://www.frontiersin.org/articles/10.3389/falgy.2021.676075/full
work_keys_str_mv AT mikaelasekkidou nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation
AT leilanimuhardi nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation
AT constantinaconstantinou nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation
AT urszulakudla nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation
AT yvanvandenplas nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation
AT nicolaosnicolaou nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation
AT nicolaosnicolaou nutritionalmanagementwithacaseinbasedextensivelyhydrolysedformulaininfantswithclinicalmanifestationsofnonigemediatedcmpaenteropathiesandconstipation